Articles Archives - Page 424 of 762

TuesdayJul 13, 2021 9:00 am

Powerful Antioxidant Nanoemulsion Development Lights Up the Profile of Pressure BioSciences Inc. (PBIO)

Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) specializes in the use of ultra-high pressure technologies to innovate unexpected and potent solutions for a wide variety of industries, including biomarker and target discovery, forensics, counter-bioterror applications, improved quality and economics for biopharmaceuticals, and safer, more potent and more cost-effective, storage, dosing and absorption of nutrients, nutraceuticals, cosmeceuticals, agrochemicals for plants, and more Pressure BioSciences recently announced the development of extraordinarily effective dosing and delivery in uniform nanoemulsions of 30 to 60 nm droplets for the powerful antioxidant astaxanthin (“AsX”), and suitable for many other prospective nutraceuticals PBIO’s technology for nanoemulsions…

TuesdayJul 13, 2021 9:00 am

Rock-Solid Business Model, String of Big Box Contracts Point to Another Record-Breaking Year For Sustainable Green Team, Ltd. (SGTM)

SGTM transforms storm, hurricane waste into environmentally beneficial products that enhance, fortify the earth Company on solid growth trajectory with string of lucrative contracts awarded in recent months Clients include municipal governments, large commercial retailers including The Kroger Co, Circle K, Menards Inc. & Old Castle Lawn & Garden 2020 was record-breaking year, Q1-2021 results include QoQ increases of 16.7% in revenue and 8.6% in gross profit Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, is on a growth trajectory with a lucrative string of large commercial contracts, a rock-solid…

MondayJul 12, 2021 1:13 pm

HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Completes Acquisition of Sagely Naturals as it Eyes Continued Growth in 2021 and Beyond

HempFusion Wellness closed the acquisition of Sagely Naturals, a women-centric CBD company, for an initial consideration of US$25 million in cash and stock payments The acquisition is expected to benefit both parties in various ways, including by increasing HempFusion’s revenue and providing access to Sagely’s extensive distribution footprint On its part, Sagely will benefit from HempFusion’s regulatory compliance, which will help in the introduction of ingestible CBD products HempFusion is looking forward to driving shareholder value through continued growth both domestically and internationally with its expanding family of brands In fulfillment of a merger agreement announced in late May, Denver-based…

MondayJul 12, 2021 1:03 pm

Q1 Productions’ 2nd Annual Medical Device Biocompatibility & Toxicology Risk Assessment Conference To Offer Safe Medical Testing Strategies For Commercial Markets

Date: July 21-23, 2021 Virtual Event Companies and professionals from the biocompatibility, toxicology, materials engineering, and related medical fields are invited to attend the Q1 Productions’ 2nd Annual Medical Device Biocompatibility & Toxicology Risk Assessment Conference being held on July 21-23, 2021. Industry leaders and regulatory authorities will share presentations discussing compliant design and commercialization evaluation processes for medical device professionals to develop safe testing strategies. This online streaming conference is a great opportunity for you to meet and collaborate with industry professionals to ensure your products meet biological safety requirements as per the global safety standards. The event will…

MondayJul 12, 2021 12:31 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Marks Major Milestone for its Rapid Point-Of-Care Diagnostic Business Strategy

XPhyto began delivery of approximately 1,000 Covid-ID Lab test kits in Berlin This marks a significant achievement commercially, as well as for the company’s point-of-care diagnostic business strategy The lab tests are designed to offer reliable Covid-19 test results in under 25 minutes XPhyto plans to capitalize on the rapid test market, projected to reach $39.1 billion by 2023 For the week starting June 27, 2021, XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) began delivery of approximately 1,000 Covid-ID Lab test kits to 10 different test centers in Berlin, Germany. This move is a major commercial achievement for the…

MondayJul 12, 2021 12:20 pm

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Is ‘One to Watch’

Avricore Health Inc. is a pharmacy solutions provider that combines best-in-class point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues The company’s wholly owned subsidiary, HealthTab, offers fast, accurate and cost-effective point-of-care screening Its current test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR); HealthTab has also recently added capabilities for bacterial and viral tests, such as strep and COVID-19 The company leverages strategic partnerships with notable names in the diagnostic space, including Abbott Rapid Diagnostics, to offer high quality,…

MondayJul 12, 2021 11:17 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Delists from CSE to Focus Efforts on Most Effective Drug Platform Outcomes

Lexaria Bioscience is a drug bioavailability platform developer intent on providing an effective oral administration alternative to smoking that duplicates the rapid assimilation benefits of inhalation without the lung-harmful effects The company’s DehydraTECH IP is being evaluated for concentration levels, tolerability and ability to transform partner drugs to oral solutions without incidentally creating new molecular entities Lexaria announced voluntary delisting from the Canadian Securities Exchange this month in order to focus its resources more effectively on its Nasdaq listing The company’s leadership recently interacted with investors in the Life Sciences Investor Forum virtual conference series and the company’s annual meeting…

FridayJul 09, 2021 11:14 am

Ideanomics Inc. (NASDAQ: IDEX) EV Tractor Subsidiary Names CEO as EV Market Continues Global Growth, Evolution

Zero-emissions electric tractor manufacturer Solectrac recently announced that agriculture and construction industry veteran Mani Iyer will succeed the company’s founder as CEO as Solectrac enters an anticipated period of new growth Solectrac is a subsidiary of clean energy-focused company Ideanomics Inc., which announced its 100 percent acquisition of the EV tractor manufacturer and distributor last month The electric vehicle (“EV”) market continues its push toward maturity as many of the world’s governments struggle to enact systemic change to their energy policies as a response to persistent concerns about the global climate (https://ibn.fm/9iw8G). New York-based EV company Ideanomics (NASDAQ: IDEX) is…

FridayJul 09, 2021 10:52 am

FingerMotion Inc. (FNGR) Continues to Push the Envelope in the Insurance Industry with Latest Subsidiary Partnership

FingerMotion’s subsidiary Xunlian Tianxia Technology entered into an agreement with Happy Life Insurance to create an innovative, data-driven insurance business model The model aims to develop new insurance products that can address real consumers’ needs by combining Xunlian’s data mining and customer profiling experience with Happy Life’s insurance expertise The new collaboration follows a similar announcement earlier this year in which FingerMotion partnered with Pacific Life Re-Insurance FingerMotion expects multiple contracts relating to its insurtech products before the end of calendar 2021 New technologies such as big data, blockchain, the Internet of Things (“IoT”), artificial intelligence (“AI”), and cloud computing…

Site Search

Company Search

Category: Articles